Featured Research

from universities, journals, and other organizations

Black Patients With Terminal Cancer More Likely To Choose Aggressive Care At End Of Life

Date:
May 30, 2008
Source:
Dana-Farber Cancer Institute
Summary:
Black patients with advanced cancer were more likely than whites to die in a hospital intensive care unit, reflecting a greater preference among blacks for life-extending treatment even in the face of a terminal prognosis, according to a study led by researchers at Dana-Farber Cancer Institute in Boston.

Black patients with advanced cancer were more likely than whites to die in a hospital intensive care unit, reflecting a greater preference among blacks for life-extending treatment even in the face of a terminal prognosis, according to a study led by researchers at Dana-Farber Cancer Institute in Boston.

Related Articles


The findings (abstract 6506) will be presented at the annual meeting of the American Society of Clinical Oncology in Chicago on Monday, June 2.

The report included interview data showing that blacks more often answered yes to questions such as, "Would you want the doctors here to do everything they can to keep you alive, even if you were going to die in a day or two?"

"This is the first study focused on black/white differences that prospectively asked [terminal cancer patients] what kind of care they wanted at the end of life, and then documented the kind of care they actually received and the place of their death," said Elizabeth Trice, MD, PhD, of Dana-Farber, lead author. Although they ruled out a number of possible explanations for the black/white differences, the investigators weren't able to identify precisely why blacks tended to prefer more-aggressive care.

"There is something different about the way black patients and white patients approach the end of life," Trice said, which may be based in cultural attitudes, religious beliefs, and how thoroughly they have been informed about and comprehend their prognosis, among other things.

Data on the preferences was obtained from the Coping with Cancer study led by Holly Prigerson, PhD, director of the Center for Psycho-social Oncology and Palliative Care Research at Dana-Farber and an associate professor of psychiatry at Harvard Medical School. That study is recruiting 800 cancer patients and their informal caregivers, such as family members.

The researchers recorded the location of death for 231 white and 61 black patients who had stage IV metastatic cancer, and who had been interviewed when they entered the study. Black patients were over four times more likely to die in a hospital ICU than white patients, they found.

The researchers, using multivariable models, found that the increased likelihood of dying in the ICU for black compared to white patients was not explained by differences in education, physical or mental health, insurance, social support, doctor-patient communication, or advance care planning, when taking into account the patient's own preference for more-aggressive care. It was clear that a patient's preference for aggressive care was the strongest factor in predicting death in an ICU.

In their initial interviews, black patients reported having a higher quality of life than their white counterparts and appeared more at peace, Trice said, which could be a factor in opting for a treatment plan aimed at extending life.

Prigerson, the senior author of the study, said the crucial question to be explored is whether the treatment preferences that explain the black/white disparities in ICU death are informed preferences or not. Toward that end, Trice has developed a research tool for assessing patients' knowledge of risks and benefits of life-extending therapies. If further research determines that blacks and whites are not equally well-informed about these risks and benefits, interventions aimed at eliminating this disparity should be considered, said the scientists.

The study's co-authors are Matthew Nilsson, Alexi Wright, MD, Tracy Balboni, MD, K. "Vish" Viswanath, PhD, and Karen Emmons, PhD, of Dana-Farber; Susan DeSanto-Madeya, RN, DNS, of the University of Massachusetts, Boston; and M. Elizabeth Paulk, MD, and Heather Stieglitz, PhD, of the University of Texas Southwestern Medical Center, Dallas.


Story Source:

The above story is based on materials provided by Dana-Farber Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Dana-Farber Cancer Institute. "Black Patients With Terminal Cancer More Likely To Choose Aggressive Care At End Of Life." ScienceDaily. ScienceDaily, 30 May 2008. <www.sciencedaily.com/releases/2008/05/080530095432.htm>.
Dana-Farber Cancer Institute. (2008, May 30). Black Patients With Terminal Cancer More Likely To Choose Aggressive Care At End Of Life. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2008/05/080530095432.htm
Dana-Farber Cancer Institute. "Black Patients With Terminal Cancer More Likely To Choose Aggressive Care At End Of Life." ScienceDaily. www.sciencedaily.com/releases/2008/05/080530095432.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins